Company name: Synbionik
Description: Provider of genetically modified microorganisms and matching bioreactor systems for the production of chemical compounds. The company focuses on the biosynthetic production of cannabinoids like cannabidiol (CBD), cannabigerol (CBG) and tetrahydrocannabinol, enabling biotech engineers to get cannabis-based devices and medicines.
Year founded: 2019
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company raised venture funding from Heartbeat Labs on an undisclosed date.
Number of active investors:
Profile last updated: 04-Nov-2019
Last known valuation:
Last known valuation date: